AB Science S.A. announced the reorganization of its Board of Directors with the co-optation of four new independent directors, Cécile de Guillebon, replacing Nathalie Riez, Catherine Johnston-Roussillon, replacing Emmanuel Mourey, Guillemette Latscha, replacing Béatrice Bihr, and Renaud Sassi, replacing Jean-Pierre Kinet.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.972 EUR | +4.45% | -5.19% | -44.53% |
13/05 | AB Science: European patent granted for masitinib | CF |
03/05 | AB Science: upbeat after legal success | CF |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-44.53% | 107M | |
+16.34% | 79.03B | |
+8.48% | 8.78B | |
-16.33% | 4.83B | |
+51.22% | 4.65B | |
+2.18% | 3.89B | |
+20.51% | 2.34B | |
-26.79% | 2.18B | |
+15.12% | 2.11B | |
-36.56% | 2B |
- Stock Market
- Equities
- AB Stock
- News AB Science
- AB Science S.A. Announces Changes in the Board of Directors